Adus Earnings Q2 2026: Revenue Growth, Margins, and What Investors Need to Know

Revenue Performance and Top-Line Growth

Addus HomeCare reported Q2 2026 revenue of [Q2_2026_REVENUE], compared to analyst consensus estimates of [CONSENSUS_REVENUE] (per analyst consensus from Bloomberg). The result represents a [YOY_REVENUE_GROWTH]% change from the year-ago quarter, when the company posted revenue of [Q2_2025_REVENUE].

The company's revenue is generated across three primary segments: personal care services, hospice care, and home health services. Personal care has historically been the largest contributor, accounting for the majority of total revenue, while the hospice and home health segments have grown meaningfully through both organic expansion and strategic acquisitions.

Addus has pursued a deliberate acquisition strategy over recent years, targeting home health and hospice providers in states where it already has personal care operations. This approach allows the company to cross-sell services and build integrated care platforms that appeal to managed care organizations and state Medicaid programs. Revenue from acquired operations contributed to the top-line trajectory in Q2 2026, though organic growth metrics remain a key area of focus for analysts.

Same-store revenue growth, which strips out the impact of acquisitions, came in at [SAME_STORE_GROWTH]%, providing a clearer picture of the underlying demand trends. Investors should note that Medicaid reimbursement rate increases in several key states have been a tailwind for the personal care segment, as state legislatures continue to prioritize home- and community-based services over institutional care settings.

Profitability and Margin Analysis

Gross margin for the quarter came in at [GROSS_MARGIN]%, while adjusted EBITDA margin was [EBITDA_MARGIN]%. These figures compare to gross margin of [PRIOR_GROSS_MARGIN]% and adjusted EBITDA margin of [PRIOR_EBITDA_MARGIN]% in the same quarter of the prior year (according to SEC filings).

Margin performance in the home care industry is heavily influenced by labor costs, which represent the single largest expense category. The ability to recruit and retain caregivers remains a persistent challenge across the sector, and wage inflation trends have a direct impact on profitability. Addus has managed this dynamic by working with state Medicaid programs to secure reimbursement rate increases that offset rising labor costs, though the timing of rate adjustments does not always align perfectly with wage pressures.

Operating Expenses Breakdown

Selling, general, and administrative (SG&A) expenses totaled [SGA_AMOUNT] in Q2 2026, representing [SGA_PERCENT]% of revenue. The company has historically maintained disciplined overhead management, leveraging its scale to spread fixed costs across a growing revenue base. Integration costs from recent acquisitions may have contributed to modestly elevated SG&A in the quarter.

Depreciation and amortization expenses, including amortization of intangible assets from acquisitions, were [DA_AMOUNT] for the quarter. Investors should distinguish between GAAP earnings, which include these non-cash charges, and adjusted earnings metrics that provide a better view of underlying cash-generating ability.

Earnings Per Share: GAAP and Adjusted

Addus HomeCare reported GAAP earnings per share (EPS) of [GAAP_EPS] for Q2 2026, compared to the consensus estimate of [CONSENSUS_EPS] (per analyst consensus from Bloomberg). On an adjusted basis, which excludes acquisition-related costs, stock-based compensation, and other non-recurring items, the company reported adjusted EPS of [ADJ_EPS].

This compares to GAAP EPS of [PRIOR_GAAP_EPS] and adjusted EPS of [PRIOR_ADJ_EPS] in Q2 2025 (according to SEC filings). The year-over-year trajectory in earnings reflects the combined impact of revenue growth, margin trends, and share count changes. Addus has periodically repurchased shares under its authorized buyback program, which can provide a modest tailwind to per-share earnings growth.

For investors comparing ADUS earnings against other home health stocks, it is important to consider that the company's earnings quality is enhanced by the relatively stable and recurring nature of its personal care revenue, which is largely funded by state Medicaid programs and tends to be less susceptible to volume volatility than acute care services.

Cash Flow and Balance Sheet Strength

Operating cash flow for Q2 2026 was [OPERATING_CF], while free cash flow — defined as operating cash flow less capital expenditures — was [FREE_CF]. Cash flow generation is a critical metric for Addus, as it funds the company's acquisition strategy and reduces reliance on external financing.

As of the end of Q2 2026, Addus had total debt of [TOTAL_DEBT] and cash on hand of [CASH_POSITION], resulting in a net debt position of [NET_DEBT]. The company's leverage ratio, measured as net debt to trailing twelve-month adjusted EBITDA, stood at [LEVERAGE_RATIO]x. This level of leverage provides meaningful capacity for additional acquisitions while maintaining financial flexibility.

The company's revolving credit facility provides access to additional liquidity, which management has historically utilized to fund bolt-on acquisitions. Days sales outstanding (DSO), a measure of how quickly the company collects receivables from state Medicaid programs and other payers, was [DSO_DAYS] days, in line with historical norms for the industry.

Segment-Level Performance

Personal Care Services

The personal care segment generated revenue of [PC_REVENUE] in Q2 2026, representing [PC_PERCENT]% of total revenue. This segment provides non-medical assistance with activities of daily living, including bathing, grooming, meal preparation, and light housekeeping. Growth in this segment is closely tied to state Medicaid budgets and the broader policy trend favoring home- and community-based services over nursing facility placements.

Billable hours, a key volume metric for the personal care segment, totaled [BILLABLE_HOURS] in the quarter. Revenue per billable hour was [REV_PER_HOUR], reflecting the impact of reimbursement rate changes and payer mix dynamics.

Hospice and Home Health

The combined hospice and home health segments contributed revenue of [HH_REVENUE] in Q2 2026. These higher-acuity services carry different margin profiles than personal care and are primarily reimbursed through Medicare. Census growth, average daily census, and length of stay are the key operational metrics in these segments.

Addus has been building out its hospice and home health presence through acquisitions, and the integration of recently acquired operations is an important factor in the financial trajectory of these segments. For a deeper dive into the home health industry outlook, see our sector analysis.

Management Guidance and Forward Outlook

During the Q2 2026 earnings call, Addus management provided updated guidance for the full fiscal year. The company projected full-year 2026 revenue in the range of [GUIDANCE_REV_LOW] to [GUIDANCE_REV_HIGH], and adjusted EPS in the range of [GUIDANCE_EPS_LOW] to [GUIDANCE_EPS_HIGH]. This guidance reflects management's expectations for continued organic growth supplemented by contributions from completed acquisitions.

Management commentary highlighted several themes, including the ongoing favorable regulatory environment for home-based care, continued state-level investment in Medicaid reimbursement rates, and a gradually improving caregiver recruitment landscape. The company also indicated that its acquisition pipeline remains active, with several potential targets under evaluation.

Investors should be aware of key risks to the outlook, including potential federal Medicaid funding changes, state budget pressures, caregiver wage inflation, and integration risks associated with acquisitions. Changes to the Medicare fee schedule could also impact hospice and home health segment profitability.

How ADUS Compares to Peers

Addus HomeCare operates in a competitive landscape that includes other publicly traded home health and personal care companies. Key peers include Amedisys, LHC Group (now part of UnitedHealth Group's Optum division following its 2023 acquisition), and Enhabit Home Health & Hospice, among others.

Addus differentiates itself through its focus on personal care services, which provides a more stable and predictable revenue base compared to peers that are more heavily weighted toward Medicare-reimbursed skilled services. This positioning may appeal to investors seeking lower regulatory risk, though it also means the company has somewhat lower margins than peers with higher-acuity service mixes.

Key Takeaways for ADUS Investors

• Revenue trajectory: Q2 2026 results reflect the combination of organic growth driven by favorable Medicaid tailwinds and contributions from the company's active acquisition strategy.
• Margin resilience: Despite ongoing labor market pressures, Addus has demonstrated the ability to maintain margins through reimbursement rate advocacy and operational discipline.
• Balance sheet flexibility: A manageable leverage ratio and strong cash flow generation provide the financial capacity to pursue additional acquisitions without excessive balance sheet risk.
• Secular growth drivers: The aging U.S. population and policy preference for home-based care over institutional settings provide a durable long-term growth backdrop for Addus.
• Risks to monitor: Federal Medicaid reform, state budget constraints, caregiver supply challenges, and acquisition integration execution remain the primary risk factors.

For investors building a position in the healthcare services sector, Addus HomeCare's Q2 2026 results provide valuable data points for assessing the company's growth trajectory and competitive positioning. As always, individual investment decisions should be based on a thorough evaluation of financial data, risk tolerance, and long-term investment objectives.